Showing 1 - 6 results of 6 for search 'Diethelm Messinger', query time: 0.03s Refine Results
  1. 1
    A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.

    A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin. by Tarik Asselah, Alex J Thompson, Robert Flisiak, Manuel Romero-Gomez, Diethelm Messinger, Georgios Bakalos, Mitchell L Shiffman

    Published 2016-01-01
    Get full text
    Article
  2. 2
    First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE

    First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE by Christophe Le Tourneau, Massimo Ghiani, Maria Chiara Cau, Roberta Depenni, Graziana Ronzino, Pierluigi Bonomo, Vincenzo Montesarchio, Luigi Leo, Jeltje Schulten, Satu Salmio, Diethelm Messinger, Andrea Sbrana, Edith Borcoman, Maria Grazia Ghi

    Published 2023-05-01
    Get full text
    Article
  3. 3
    Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.

    Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia. by Evelyn Klein, Dietmar Schlembach, Angela Ramoni, Elena Langer, Franz Bahlmann, Sabine Grill, Helene Schaffenrath, Reinhard van der Does, Diethelm Messinger, Wilma D J Verhagen-Kamerbeek, Manfred Reim, Martin Hund, Holger Stepan

    Published 2016-01-01
    Get full text
    Article
  4. 4
    Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B.

    Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B. by Patrick Marcellin, Qing Xie, Seung Woon Paik, Robert Flisiak, Teerha Piratvisuth, Jörg Petersen, Tarik Asselah, Markus Cornberg, Denis Ouzan, Graham R Foster, Georgios Papatheodoridis, Diethelm Messinger, Loredana Regep, Georgios Bakalos, Ulrich Alshuth, Pietro Lampertico, Heiner Wedemeyer

    Published 2020-01-01
    Get full text
    Article
  5. 5
    A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer

    A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Local... by Markus Hecht, Dennis Hahn, Philipp Wolber, Matthias G. Hautmann, Dietmar Reichert, Steffi Weniger, Claus Belka, Tobias Bergmann, Thomas Göhler, Manfred Welslau, Christina Große-Thie, Orlando Guntinas-Lichius, Jens von der Grün, Panagiotis Balermpas, Katrin Orlowski, Diethelm Messinger, Karsten G. Stenzel, Rainer Fietkau

    Published 2021-07-01
    Get full text
    Article
  6. 6
    Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

    Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer by Markus Hecht, Dennis Hahn, Philipp Wolber, Matthias G. Hautmann, Dietmar Reichert, Steffi Weniger, Claus Belka, Tobias Bergmann, Thomas Göhler, Manfred Welslau, Christina Große-Thie, Orlando Guntinas-Lichius, Jens von der Grün, Panagiotis Balermpas, Katrin Orlowski, Diethelm Messinger, Karsten G. Stenzel, Rainer Fietkau

    Published 2020-09-01
    Get full text
    Article

Search Tools: